SEC Comment Letter for CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — May 8, 2018

CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: May 8, 2018 · CIK: 0001175680 · Accession: 0000000000-18-014258

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-49908

Date

May 8, 2018

Author

Nader Pourhassan, Ph.D.

Form

UPLOAD

Company

CytoDyn Inc. (CYDY) (CIK 0001175680)

Letter

May 8, 2018 Nader Pourhassan, Ph.D. Chief Executive Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, WA 98660 Re:CytoDyn Inc. Preliminary Proxy Statement on Schedule 14A Filed April 26, 2018 File No. 000-49908 Dear Dr. Pourhassan: We have completed our review of your filing on May 7, 2018. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Division of Corporation Finance Office of Healthcare & Insurance cc: Steven Skolnick

Show Raw Text

May 8, 2018
Nader Pourhassan, Ph.D.
Chief Executive Officer
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, WA 98660
Re:CytoDyn Inc.
Preliminary Proxy Statement on Schedule 14A
Filed April 26, 2018
File No. 000-49908
Dear Dr. Pourhassan:
            We have completed our review of your filing on May 7, 2018.  We remind you that the
company and its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Steven Skolnick

SecProbe.io